Publicaciones en las que colabora con ROSARIO GIL BENSO (35)

2021

  1. The status of egfr modulates the effect of mirna-200c on zeb1 expression and cell migration in glioblastoma cells

    International Journal of Molecular Sciences, Vol. 22, Núm. 1, pp. 1-18

2020

  1. Pam3CSK4, a TLR2 ligand, induces differentiation of glioblastoma stem cells and confers susceptibility to temozolomide

    Investigational New Drugs, Vol. 38, Núm. 2, pp. 299-310

2019

  1. Characterization of a new glioblastoma cell line, GB-val4, with unusual TP53 mutation

    Human Cell, Vol. 32, Núm. 4, pp. 557-567

  2. Epigenetic changes underlie the aggressiveness of histologically benign meningiomas that recur

    Human Pathology, Vol. 84, pp. 105-114

2018

  1. Study of the activation of TLR receptors in neurospheres from glioblastoma cells in vitro

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii12

2017

  1. Association between epidermal growth factor receptor amplification and ADP-ribosylation factor 1 methylation in human glioblastoma

    Cellular Oncology, Vol. 40, Núm. 4, pp. 389-399

  2. Characterization of the new human pleomorphic undifferentiated sarcoma TP53-null cell line mfh-val2

    Cytotechnology, Vol. 69, Núm. 4, pp. 539-550

  3. Molecular progression in unusual recurrent non-pediatric intracranial clear cell meningioma

    Current Oncology, Vol. 24, Núm. 3, pp. e244-e250

2015

  1. Alteration of major vault protein in human glioblastoma and its relation with EGFR and PTEN status

    Neuroscience, Vol. 297, pp. 243-251

  2. Evolution to malignancy: A genetic stepwise study of tumor suppressor genes loss in a recurrent meningioma

    Clinical Neuropathology

  3. Expression of the Chemokine Receptors CXCR3, CXCR4, CXCR7 and Their Ligands in Rhabdomyosarcoma

    Pathology and Oncology Research, Vol. 21, Núm. 4, pp. 1191-1199

2014

  1. BRAF V600E mutation in two distinct meningeal melanocytomas associated with a nevus of ota

    Journal of Clinical Oncology, Vol. 32, Núm. 20

  2. Correlation between EGFR amplification and the expression of MicroRNA-200c in primary glioblastoma multiforme

    PLoS ONE, Vol. 9, Núm. 7

2013

  1. Chromosomal and genetic changes produced in tumoral progression of embryonal rhabdomyosarcoma

    Histopathology

  2. Gene Expression Profiles of Metabolic Aggressiveness and Tumor Recurrence in Benign Meningioma

    PLoS ONE, Vol. 8, Núm. 6

  3. Genetic changes with prognostic value in histologically benign meningiomas

    Clinical Neuropathology, Vol. 32, Núm. 4, pp. 311-317

2012

  1. Characterization of a new human melanoma cell line with CD133 expression

    Human Cell, Vol. 25, Núm. 2, pp. 61-67

  2. Meningioma tumors: Detection of subgroups

    Tumors of the Central Nervous System, Volume 7: Meningiomas and Schwannomas (Springer Netherlands), pp. 101-110

2010

  1. Metabolic aggressiveness in benign meningiomas with chromosomal instabilities

    Cancer Research, Vol. 70, Núm. 21, pp. 8426-8434

  2. New pattern of EGFR amplification in glioblastoma and the relationship of gene copy number with gene expression profile

    Modern Pathology, Vol. 23, Núm. 6, pp. 856-865